Repligen provides products and services to support biotherapeutic manufacturing. It offers filtration, chromatography systems, process analytics, fluid management, and protein solutions that help develop and produce biologics such as cell and gene therapies, mRNA, monoclonal antibodies, antibody–drug conjugates, bispecific antibodies, and fusion proteins. Its offerings are designed to fit the full bioprocess workflow—from upstream filtration and purification to downstream analytics and process control—through a portfolio of systems, consumables, and services. Repligen differentiates itself by maintaining a broad, integrated suite of bioprocessing technologies and global manufacturing support across 22 sites, enabling clients to scale from development to commercial production. The company’s goal is to advance and accelerate the manufacturing of biologics by providing reliable, end-to-end solutions that streamline development and scale-up.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Waltham, Massachusetts
Founded
1981
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?